Patient of 65 year old with severe recurrent vomitting weakly once
Reading File
Asking for Preferences
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Now I have enough from authoritative textbooks to give a thorough, structured answer. Here is the full clinical management guide:
Management of Severe Recurrent Vomiting in a 65-Year-Old on Medications
Step 1 - Identify the Drug Cause First
In a 65-year-old on medications, the most important first step is to identify which drug is driving the vomiting, because this determines treatment. Common culprits:
| Drug Class | Mechanism of Vomiting |
|---|---|
| NSAIDs (ibuprofen, diclofenac, aspirin) | Mucosal irritation, gastritis, peptic ulceration |
| Opioids (morphine, codeine, tramadol) | Stimulate chemoreceptor trigger zone (CTZ); delay gastric emptying |
| Chemotherapy agents | Serotonin (5-HT3) and substance P (NK1) release; highly emetogenic |
| Digoxin / antiarrhythmics | Direct CTZ stimulation (narrow therapeutic index in elderly) |
| Metformin / GLP-1 agonists | GI mucosal irritation; delayed gastric emptying |
| Antibiotics (e.g., erythromycin, azithromycin) | GI dysmotility |
Step 2 - General Principles of Management
From Harrison's Principles of Internal Medicine 22E:
"Therapy of vomiting is tailored to correct remediable abnormalities if possible. If feasible, medications deemed to contribute to a patient's nausea should be discontinued or their doses reduced."
Key general measures:
- Correct dehydration and electrolytes (hypokalemia and metabolic alkalosis are common consequences of recurrent vomiting)
- Start with low-fat, small-particle, small frequent meals (4-6 meals/day)
- Avoid carbonated drinks, high-fiber foods, and fats (all worsen gastroparesis)
- Optimize glycemic control in diabetics (hyperglycemia itself inhibits gastric emptying)
Step 3 - Drug-Specific Management
A. If on NSAIDs
- Stop or reduce the NSAID if possible
- Switch to a COX-2 inhibitor (less GI irritation) or use topical NSAIDs
- Add a Proton Pump Inhibitor (omeprazole 20 mg OD, pantoprazole 40 mg OD) to protect the gastric mucosa
- Upper endoscopy if symptoms persist to exclude peptic ulcer or hemorrhagic gastritis
B. If on Opioids (Opioid-Induced Nausea/Vomiting - OINV)
From Miller's Anesthesia 10E:
"Antiemetic medication should also be given to prevent opioid-induced nausea and vomiting... prevention and/or treatment of opioid-induced nausea and vomiting continues to be a clinical challenge."
Management:
- Reduce opioid dose if pain is controlled, or rotate to a different opioid (e.g., switch from morphine to oxycodone or fentanyl - different receptor profiles)
- Metoclopramide 10 mg TDS (before meals) - prokinetic + D2 antagonist; improves gastric emptying - first-line for OINV
- Ondansetron 4-8 mg BD/TDS - 5-HT3 antagonist; excellent for opioid-related emesis
- Haloperidol 0.5-1.5 mg can be used as an adjunct (D2 antagonist at CTZ)
- Consider naloxegol or methylnaltrexone (peripherally-acting opioid antagonists) if opioid-induced gastroparesis is confirmed
C. If on Chemotherapy (CINV)
From Washington Manual of Medical Therapeutics:
"Commonly used antiemetic medications for prevention and management of CINV include dexamethasone, 5-HT3 receptor antagonists (ondansetron, granisetron, palonosetron), NK1 receptor antagonists (aprepitant, fosaprepitant), prochlorperazine, lorazepam, and olanzapine."
Graded approach based on emetogenicity:
- Low emetogenicity: Dexamethasone 8 mg + ondansetron 8 mg before each cycle
- Moderate emetogenicity: Dexamethasone + ondansetron + olanzapine 10 mg
- High emetogenicity (e.g., cisplatin): Triple therapy - NK1 antagonist (aprepitant 125 mg) + 5-HT3 antagonist + dexamethasone, +/- olanzapine
Step 4 - Antiemetic Drug Table (by Mechanism)
From Yamada's Textbook of Gastroenterology 7E and Harrison's 22E:
| Drug Class | Agent & Dose | Best For | Key Side Effects in Elderly |
|---|---|---|---|
| D2 antagonist (prokinetic) | Metoclopramide 5-10 mg TDS before meals | Gastroparesis, OINV | Tardive dyskinesia (limit to <12 weeks), anxiety, dystonia |
| Peripheral D2 antagonist | Domperidone 10 mg TDS (not available in USA) | Gastroparesis | QTc prolongation - ECG monitoring needed |
| 5-HT3 antagonist | Ondansetron 4-8 mg BD-TDS | CINV, OINV, postoperative | Constipation, headache, QTc prolongation |
| Antihistamine | Promethazine 25 mg every 4-6h; Meclizine 25 mg OD | Motion sickness, labyrinthine, PONV | Sedation, dry mouth - use cautiously in elderly (Beers Criteria) |
| Anticholinergic | Scopolamine patch 1.5 mg/72h | Motion sickness | Urinary retention, blurred vision, confusion in elderly |
| NK1 antagonist | Aprepitant 125 mg day 1, 80 mg days 2-3 | CINV (high emetogenicity) | Drug interactions (CYP3A4) |
| Corticosteroid | Dexamethasone 8-12 mg | Adjunct in CINV | Hyperglycemia, insomnia |
| Atypical antipsychotic | Olanzapine 5-10 mg OD | CINV, refractory vomiting | Sedation, metabolic syndrome |
| Benzodiazepine | Lorazepam 0.5-1 mg | Anticipatory CINV, anxiolytic | Sedation, falls risk in elderly |
Step 5 - Special Considerations in the Elderly (65+)
- Avoid first-generation antihistamines (promethazine, diphenhydramine) as first-line - listed on the Beers Criteria for inappropriate use in the elderly due to falls and cognitive effects
- Metoclopramide - use lowest effective dose, avoid prolonged use (>12 weeks) due to risk of tardive dyskinesia, which is more common in elderly women
- Domperidone - requires ECG before use; QTc prolongation risk is higher in elderly
- Ondansetron is generally well-tolerated in the elderly but watch for constipation and QTc (especially if on other QT-prolonging drugs)
- Dose reduction for most antiemetics needed given reduced hepatic/renal clearance with aging
Step 6 - When to Refer / Escalate
- Vomiting with haematemesis or coffee-ground material - urgent endoscopy (ulcer/malignancy)
- Signs of bowel obstruction (abdominal distension, absolute constipation)
- Neurological symptoms (headache, diplopia) - consider CNS cause
- Weight loss >10% in 6 months - malignancy workup
- Persistent vomiting despite drug withdrawal and antiemetics - gastric emptying study (scintigraphy) to confirm gastroparesis
- Severe dehydration or electrolyte imbalance requiring IV fluids - hospital admission
Summary Algorithm:
- Identify and stop/reduce the offending drug
- Correct fluids and electrolytes
- Start a prokinetic (metoclopramide) + antiemetic (ondansetron) combination
- Add PPI if NSAID-related
- Use NK1 + 5-HT3 + dexamethasone triple therapy if chemotherapy-related
- Monitor QTc, renal function, and for extrapyramidal effects in this age group
Sources: Harrison's Principles of Internal Medicine 22E, p.342 | Yamada's Textbook of Gastroenterology 7E, p.667 | Washington Manual of Medical Therapeutics | Miller's Anesthesia 10E
This is a shared conversation. Sign in to Orris to start your own chat.